Skip to main content

Table 3 Sensory nerve conduction measurements

From: Omega-3 fatty acids are protective against paclitaxel-induced peripheral neuropathy: A randomized double-blind placebo controlled trial

  Group Pre-chemotherapy Post-chemotherapy* p-value #
Sural nerve     
a-SAP(μV) Omega 3 13.27 (5.02) 13.33 (5.91) .015
  Placebo 13.70 (7.46) 9.74 (5.96)  
SCV(m/s) Omega 3 54.35 (7.13) 54.79 (8.35) .514
  Placebo 53.50 (6.79) 52.52 (8.05)  
Ulnar nerve     
a-SAP(μV) Omega 3 34.23 (14.85) 24.53 (13.95) .454
  Placebo 31.15 (14.02) 21.53 (13.70)  
SCV(m/s) Omega 3 57.30 (5.18) 55.82 (6.35) .212
  Placebo 55.80 (4.90) 53.19 (7.29)  
  1. a-SAP, sensory action potential amplitude; SCV, sensory conduction velocity.
  2. * One month after the cessation of chemotherapy.
  3. # p value is reported based on the analysis of covariance.